Patents by Inventor Ryohei TANIGAWA

Ryohei TANIGAWA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Control device, information processing device, and information processing method for instructing movement of a vehicle detachably connected to or loaded on another vehicle
    Patent number: 11938970
    Abstract: A control device that is mounted in a second vehicle which a first vehicle having a following travel function is detachably connected to or loaded on is provided. The control device includes a control unit configured to perform: detecting another vehicle that is within a predetermined range from the second vehicle in a state in which the second vehicle has the first vehicle connected thereto or loaded thereon and of which some or all of a scheduled travel route is the same as some or all of a scheduled travel route of the first vehicle after the first vehicle has been disconnected from the second vehicle; and transmitting following instruction information to the first vehicle and disconnecting the first vehicle from the second vehicle such that the first vehicle travels with the detected other vehicle as a preceding vehicle by the following travel function.
    Type: Grant
    Filed: February 25, 2021
    Date of Patent: March 26, 2024
    Assignee: TOYOTA JIDOSHA KABUSHIKI KAISHA
    Inventors: Takahiro Harada, Teppei Nishiguchi, Kazuki Komoriya, Tomoaki Ihara, Miyu Higashimura, Toshihiro Nakaichi, Kazunobu Okasaka, Ryo Hattori, Yohei Tanigawa, Ryohei Kimbara, Hiroshi Nakamura
  • Medicament containing pemafibrate
    Patent number: 11419854
    Abstract: To provide an appropriate method of treatment with pemafibrate for a liver cirrhosis patient. The present invention relates to the use of pemafibrate in a liver cirrhosis patient. More particularly, the present invention relates to a regimen for administering a reduced dose of pemafibrate to a liver cirrhosis patient in need of treatment with pemafibrate than to persons with normal liver function.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: August 23, 2022
    Assignee: KOWA COMPANY, LTD.
    Inventors: Satoshi Kojima, Ryohei Tanigawa
  • AGENT FOR TREATMENT OF PBC
    Publication number: 20210069157
    Abstract: The present invention relates to a pharmaceutical composition for the treatment of primary biliary cirrhosis (PBC), in which containing a therapeutically effective amount of (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy] butyric acid, a salt thereof, or a solvate thereof.
    Type: Application
    Filed: February 24, 2017
    Publication date: March 11, 2021
    Applicant: Kowa Company, Ltd.
    Inventors: Mitsumasa NAKAMURA, Satoshi Kojima, Ryohei Tanigawa
  • MEDICAMENT CONTAINING PEMAFIBRATE
    Publication number: 20200046686
    Abstract: To provide an appropriate method of treatment with pemafibrate for a liver cirrhosis patient. The present invention relates to the use of pemafibrate in a liver cirrhosis patient. More particularly, the present invention relates to a regimen for administering a reduced dose of pemafibrate to a liver cirrhosis patient in need of treatment with pemafibrate than to persons with normal liver function.
    Type: Application
    Filed: June 29, 2018
    Publication date: February 13, 2020
    Applicant: KOWA COMPANY, LTD.
    Inventors: Satoshi KOJIMA, Ryohei TANIGAWA
  • Agent for treatment of PBC
    Patent number: 10314825
    Abstract: The present invention relates to a pharmaceutical composition for the treatment of primary biliary cirrhosis (PBC), in which containing a therapeutically effective amount of (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy] butyric acid, a salt thereof, or a solvate thereof.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: June 11, 2019
    Assignee: KOWA COMPANY, LTD.
    Inventors: Mitsumasa Nakamura, Satoshi Kojima, Ryohei Tanigawa
  • AGENT FOR TREATMENT OF PBC
    Publication number: 20180250274
    Abstract: The present invention relates to a pharmaceutical composition for the treatment of primary biliary cirrhosis (PBC), in which containing a therapeutically effective amount of (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy] butyric acid, a salt thereof, or a solvate thereof.
    Type: Application
    Filed: February 23, 2018
    Publication date: September 6, 2018
    Applicant: KOWA COMPANY, LTD.
    Inventors: Mitsumasa NAKAMURA, Satoshi KOJIMA, Ryohei TANIGAWA